Welcome to CDC Stacks | Clinicians advised to halt use of propofol from tainted lots - 25207 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Clinicians advised to halt use of propofol from tainted lots
  • Published Date:
    7/9/09
  • Source:
    HAN ; 296
  • Language:
    English
Filetype[PDF - 505.03 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration. ;
  • Series:
    HAN ; 296
  • Keywords:
  • Description:
    Monday, July 13, 2009, 19:00 EDT (7:00 PM EDT)

    CDCHAN-00296-2009-07-13-ADV-N

    The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have been investigating recent cases of febrile reactions among patients undergoing endoscopy in the United States.

    This investigation has revealed that all of the case-patients received the anesthetic propofol from 100 ml vials manufactured byTeva Pharmaceuticals.

    Testing done by the FDA has found that two lots of this product that were in use in facilities reporting febrile reactions were positive for elevated levels of endotoxin.

    The lots are 31305429B and 31305430B.

    Teva Pharmaceuticals is initiating a voluntary recall for these lots, and clinicians are advised to immediately stop using these lots of Teva Pharmaceuticals propofol.

    CDC, FDA and Teva Pharmaceuticals are continuing to investigate this issue.

  • Document Type:
    HAN Health Advisory
  • Collection(s):
    Health Alert Network (HAN)
  • Place as Subject:
    gau
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Non-safety-related voluntary recall of unused doses from certain lots of Sanofi Pasteu r H1N1 vaccine in pre-filled syringes
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.); United States. Food and Drug Administration.;
    Published:
    1/29/10
    Source:
    HAN ; 306
    Series:
    HAN ; 306
    Description:
    Friday, January 29, 2010, 19:15 EST (7:15 PM EST) : CDCHAN-00306-2010-01-29-UPD-N : As part of its quality assurance program, Sanofi Pasteur, Inc., performs routine, ongoing testing of influenza vaccines after the vaccine has been distributed to heal...
    File Type:
    Filetype[PDF - 624.97 KB]
  2. Use of laboratory test results in patient management by clinicians in Malawi
    Personal Author:
    Moyo, Kundai; Porter, Carol; Chilima, Ben; Mwenda, Reuben; Kabue, Mark; Zungu, Lutho; Sarr, Abdoulaye;
    Published:
    Nov 18 2015
    Source:
    Afr J Lab Med. 4(1).
    Description:
    Background : Malawi has a high burden of infectious disease. The expansion of programmes targeting these diseases requires a strong laboratory infrastructure to support both diagnosis and treatment. : Objectives : To assess the use of laboratory test...
    File Type:
    Filetype[PDF - 109.95 KB]
  3. Notice to clinicians : Summary of CDC recommendations for influenza antiviral medications
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    1/15/13
    Source:
    HAN ; 339
    Series:
    HAN ; 339
    Description:
    January 15, 2013, 16:00 ET : CDCHAN-00339 : CDC continues to recommend antiviral medications for treatment of seasonal influenza and annual vaccination as the best tools for prevention. : Evidence from past influenza seasons and the 2009 H1N1 pandemi...
    File Type:
    Filetype[PDF - 2.25 MB]
  4. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults
    Personal Author:
    Smith, Dawn K.; Thigpen, Michael C.; Nesheim, Steven R.; Lampe, Margaret A.; Paxton, Lynn A.; Samandari, Taraz.; Lansky, Amy.; Mermin, Jonathan.; Fenton, Kevin.;
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
    Published:
    2012 Aug 10
    Description:
    Morbidity and mortality weekly report. 2012 Aug 10;61(31):586-9. : In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009. Of these, 27% were in heterosexual men and women who did not inject drugs...
    Status:
    superseded
    File Type:
    Filetype[PDF - 96.99 KB]
  5. Notice to clinicians: Early reports of pH1N1-associated illnesses for the 2013-14 influenza season
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    12/24/13
    Source:
    HAN ; 359
    Series:
    HAN ; 359
    Description:
    December 24, 2013, 14:30 ET (2:30 PM ET) : CDCHAN-00359 : From November through December 2013, CDC has received a number of reports of severe respiratory illness among young and middle-aged adults, many of whom were infected with : influenza A (H1N1)...
    File Type:
    Filetype[PDF - 2.85 MB]